Gain Therapeutics, Inc. (GANX)
USD 1.54
(-8.33%)
USD 1.54
(-8.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.86 Million | -14.69 Million | -12.36 Million | -3.24 Million | -1.86 Million | -744.51 Thousand |
| Net Income | -22.26 Million | -17.59 Million | -13.89 Million | -3.57 Million | -2.19 Million | -1.1 Million |
| Depreciation & Amortization | 80.38 Thousand | 64.16 Thousand | 15.48 Thousand | 9592.00 | 2571.00 | 741.00 |
| Deferred income taxes | 643.16 Thousand | - | 1.08 Million | - | - | - |
| Stock-based compensation | 3.25 Million | 1.52 Million | 839.37 Thousand | 81.64 Thousand | - | - |
| Change in working capital | 442.23 Thousand | 1.51 Million | -385.11 Thousand | 237.5 Thousand | 312.26 Thousand | 319.23 Thousand |
| Other non-cash items | -1.02 Million | -206.86 Thousand | -34.13 Thousand | 8709.00 | 10.1 Thousand | 41.05 Thousand |
| Investing Cash Flow | 10.22 Million | -14.77 Million | -94.21 Thousand | -20.82 Thousand | -13.72 Thousand | -7987.00 |
| Investments in PPE | -15.35 Thousand | -118.95 Thousand | -94.21 Thousand | -20.82 Thousand | -13.72 Thousand | -7987.00 |
| Acquisitions | -10.23 Million | 14.65 Million | - | - | - | - |
| Investment purchases | -1.95 Million | -17.73 Million | - | - | - | - |
| Sales/Maturities of investments | 12.19 Million | 3.07 Million | - | - | - | - |
| Other Investing Activities | 10.23 Million | -14.65 Million | - | - | - | 7987.00 |
| Financing Cash Flow | 12.64 Million | -78.77 Thousand | 41.76 Million | 10.48 Million | 1.75 Million | 983.77 Thousand |
| Debt repayment | -89.06 Thousand | -78.77 Thousand | -21.95 Thousand | -738.28 Thousand | - | -983.77 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 12.73 Million | - | 42.64 Million | 177.00 | 1.75 Million | - |
| Other Financing Activities | 12.64 Million | -78.77 Thousand | -853.48 Thousand | 11.22 Million | 1.75 Million | 983.77 Thousand |
| Accounts receivables | -130.06 Thousand | - | 8264.00 | -196.00 | -8352.00 | - |
| Accounts payables | -643.16 Thousand | 1.06 Million | -521.39 Thousand | 395.54 Thousand | 5108.00 | 117.68 Thousand |
| Inventory | - | - | 93.31 Thousand | -28.52 Thousand | 96.51 Thousand | - |
| Other working capital | 1.08 Million | 448.15 Thousand | 34.7 Thousand | -129.31 Thousand | 218.98 Thousand | 201.54 Thousand |
| Cash at beginning of period | 7.31 Million | 36.91 Million | 7.5 Million | 313.7 Thousand | 410.88 Thousand | 173 Thousand |
| Cash at end of period | 11.79 Million | 7.34 Million | 36.91 Million | 7.5 Million | 313.7 Thousand | 410.88 Thousand |
| Capital Expenditure | -15.35 Thousand | -118.95 Thousand | -94.21 Thousand | -20.82 Thousand | -13.72 Thousand | -7987.00 |
| Effect of forex changes on cash | 488.4 Thousand | -23.79 Thousand | 100.77 Thousand | -35.31 Thousand | 33.56 Thousand | 6607.00 |
| Net cash flow / Change in cash | 4.48 Million | -29.56 Million | 29.4 Million | 7.19 Million | -97.18 Thousand | 237.88 Thousand |
| Free Cash Flow | -18.88 Million | -14.81 Million | -12.45 Million | -3.26 Million | -1.88 Million | -752.5 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.14 Million | -4.01 Million | -22.26 Million | -4.72 Million | -4.71 Million | -7.68 Million |
| Depreciation & Amortization | 20.59 Thousand | 20.52 Thousand | 80.38 Thousand | 23.58 Thousand | 20.5 Thousand | 20.23 Thousand |
| Deferred income taxes | - | - | 643.16 Thousand | -1.57 Million | - | - |
| Stock-based compensation | 1.48 Million | 190.42 Thousand | 3.25 Million | 555.05 Thousand | 907.32 Thousand | 1.23 Million |
| Change in working capital | 1.04 Million | 416.8 Thousand | 442.23 Thousand | -1.37 Million | -5180.00 | 1.36 Million |
| Other non-cash items | -125.08 Thousand | -672.25 Thousand | -1.02 Million | 1.44 Million | -171.1 Thousand | 45.85 Thousand |
| Investing Cash Flow | 2 Million | 3.01 Million | 10.22 Million | 3.14 Million | 1.92 Million | 3.04 Million |
| Investments in PPE | -21.54 Thousand | - | -15.35 Thousand | -19.00 | -650.00 | -3644.00 |
| Acquisitions | - | - | -10.23 Million | 2.11 Million | - | - |
| Investment purchases | - | - | -1.95 Million | - | - | - |
| Sales/Maturities of investments | 2.02 Million | 3.01 Million | 12.19 Million | 3.14 Million | 1.92 Million | 3.04 Million |
| Other Investing Activities | 2.02 Million | 3.01 Million | 10.23 Million | 3.14 Million | 1.92 Million | 3.04 Million |
| Financing Cash Flow | 10.03 Million | -145.8 Thousand | 12.64 Million | 9.56 Million | 134.47 Thousand | 2.19 Million |
| Debt repayment | -22.11 Thousand | -22.87 Thousand | -89.06 Thousand | -22.57 Thousand | -22.63 Thousand | -22.24 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 13.57 Thousand | 157.93 Thousand | 12.73 Million | 9.58 Million | 157.1 Thousand | 2.21 Million |
| Other Financing Activities | 10.04 Million | -280.86 Thousand | 12.64 Million | 9.58 Million | 157.1 Thousand | 2.19 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.48 Million | 703.59 Thousand | -643.16 Thousand | -976.78 Thousand | -46.1 Thousand | -677.84 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -433.72 Thousand | -286.78 Thousand | 1.08 Million | -402.57 Thousand | 40.92 Thousand | 2.04 Million |
| Cash at beginning of period | 10.64 Million | 11.79 Million | 7.31 Million | 4.27 Million | 6.35 Million | 6.01 Million |
| Cash at end of period | 16.93 Million | 10.64 Million | 11.79 Million | 11.79 Million | 4.3 Million | 6.35 Million |
| Capital Expenditure | -21.54 Thousand | - | -15.35 Thousand | -19.00 | -650.00 | -3644.00 |
| Effect of forex changes on cash | 13.12 Thousand | -442.5 Thousand | 488.4 Thousand | 483.24 Thousand | -144.57 Thousand | 111.31 Thousand |
| Net cash flow / Change in cash | 6.29 Million | -1.15 Million | 4.48 Million | 7.52 Million | -2.04 Million | 332.41 Thousand |
| Free Cash Flow | -5.77 Million | -3.58 Million | -18.88 Million | -5.66 Million | -3.96 Million | -5.02 Million |
PHL
BALM3
FND
GVDI
8027
CMPGY